Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer

OBJECTIVES: To assess the clinical value of early clearance of HE4 and CA125 for platinum sensitivity and prognosis in patients with ovarian cancer. METHOD: HE4 and CA125 value including clinical data of 89 patients with ovarian cancer were collected. The clearance of HE4 and CA125 were assessed bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Yan, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780648/
https://www.ncbi.nlm.nih.gov/pubmed/33397458
http://dx.doi.org/10.1186/s13048-020-00759-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780648/
https://www.ncbi.nlm.nih.gov/pubmed/33397458
http://dx.doi.org/10.1186/s13048-020-00759-9

Ejemplares similares